Form 8-K - Current report:
SEC Accession No. 0001104659-26-056237
Filing Date
2026-05-06
Accepted
2026-05-06 16:05:38
Documents
18
Period of Report
2026-05-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2613728d1_8k.htm   iXBRL 8-K 34733
2 EXHIBIT 1.1 tm2613722d1_ex1-1.htm EX-1.1 274120
3 EXHIBIT 5.1 tm2613722d1_ex5-1.htm EX-5.1 13655
4 EXHIBIT 99.1 tm2613722d1_ex99-1.htm EX-99.1 8939
5 EXHIBIT 99.2 tm2613722d1_ex99-2.htm EX-99.2 8696
9 GRAPHIC tm2613722d1_ex5-1img001.jpg GRAPHIC 9732
10 GRAPHIC tm2613722d1_ex99-1img001.jpg GRAPHIC 4196
11 GRAPHIC tm2613722d1_ex99-1img002.jpg GRAPHIC 2181
  Complete submission text file 0001104659-26-056237.txt   608925

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA gpcr-20260505.xsd EX-101.SCH 3023
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE gpcr-20260505_lab.xml EX-101.LAB 34239
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gpcr-20260505_pre.xml EX-101.PRE 22364
21 EXTRACTED XBRL INSTANCE DOCUMENT tm2613728d1_8k_htm.xml XML 3205
Mailing Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017 833-393-6684
HYPERION DEFI, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 26948269
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)